Conditions: Cancer
Keywords: Advanced Cancer Metastatic Cancer p70s6 inhibitor
Allocation: NA | Intervention model: SINGLE_GROUP
Enrollment: 9
Healthy volunteers: no

Brief summary:
The purpose of this study is to assess the safety and tolerability of LY2584702 in Japanese patients with advanced and/or metastatic solid tumors for which no proven effective therapy exists.

Detailed description:

Arms:
arm 1: None

Interventions: intervention 1: LY2584702
Intervention descriptions: intervention 1: Dose escalation starting at 50 milligram (mg). On Day 1, subjects will receive a single oral dose. After a two-day observation period, subjects will receive oral doses twice daily for a 28-day cycle.

Patients may continue 28-day cycles of twice daily dosing until discontinuation criteria are met.

Protocol document: